Irritable bowel syndrome: present and prospective pharmacological intervention.
Kinnier
W J
WJ
NOVA Pharmaceutical Corporation, Baltimore, Maryland 21224-2788.
Kachur
J F
JF
Audia
V H
VH
Kaiser
C
C
D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D006801:Humans